[Expression of recombinant human soluble Flt3 ligand and its in vitro effects on malignant hematopoietic cells].
OBJECTIVE
To express human soluble Flt3 ligand in a yeast expression system. Pichia pastoris, and investigate the effects of recombinant human soluble Flt3 ligand (rhFL) on the proliferation of malignant hematopoietic cells(MHC) and the effect of dexamethasone (DXM) on the expression of Flt3 receptor (Flt3R) and the rhFL induced proliferation of those cells.


METHODS
An artificial gene for rhFL was synthesized by using favored genetic codons of the yeast Pichia pastoris. Flt3R was determined by flow cytometry. Proliferation of MHCs was measured by microculture tetrazolium (MTT) assay.


RESULTS
1. An expression vector, pPICZ alpha A-FL, was constructed and electroporated into Pichia pastoris. A yield of over 30 mg/L of yeast culture supernatant was obtained. The rhFL could stimulate the proliferation of Raji and HL-60 cells at concentrations of 10-100 ng/ml, but did not for most of other MHCs. 2. Flt3R was expressed in 5 of 18 MHC lines and the expression in leukemic blast cells was widespread and extremely heterogeneous. 3. The presence of the receptor on the surface of MHC did not necessarily imply a significant ligand-induced response, at least in terms of proliferation. By contrast, some Flt3R-negative MHC responded to rhFL. 4. DXM down-regulated the expression of Flt3R and inhibited the proliferation induced by rhFL in some MHC lines and fresh leukemia cell samples.


CONCLUSIONS
A yield of 30 mg/L of rhFL was obtained. rhFL stimulated the proliferation of Raji, HL-60 cells and some fresh leukemia cells, which could be inhibited by DXM through down-regulation of Flt3R. A combination of FL and DXM might possibly serve to control hematopoietic defects in malignant hematopoietic diseases.
Department of Immunology, Soochow University, Suzhou 215007, China.
Z
Z
Xu
Y
Y
Xu
J
J
Zhu
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D003907:Dexamethasone / Q000494:pharmacology; D019337:Hematologic Neoplasms / Q000473:pathology*; D006801:Humans; D008565:Membrane Proteins / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D018931:Antineoplastic Agents, Hormonal; D008565:Membrane Proteins; D011994:Recombinant Proteins; C084881:flt3 ligand protein; D003907:Dexamethasone